Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Procrit for Prevention of Delayed Graft Function in Kidney Transplant
NCT00425126Phase 4Completed
- Sponsor
- Allegheny Health Network
- Start
- Feb 2007
- Primary completion
- Feb 2010
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 4 trial of epoetin alfa in delayed graft function (DGF), sponsored by Allegheny Health Network. Started Feb 2007; status: completed.
02
Drugs
epoetin alfa
03
Conditions
delayed graft function (DGF)
Beyond the preview
Go deeper on NCT00425126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425126.